Oxalic Acid

Oxalic Acid

SCHEMBL386563

C[C@](N)(CO)CCc1ccc(C#CCCCc2ccccc2)o1.O=C(O)C(=O)O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 1/20 0.38
POLB P06746 2/20 0.37
RECQL P46063 1/20 0.37
GRM5 P41594 1/20 0.36
GRM2 Q14416 3/20 0.34
GRM3 Q14832 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HTT P42858 1/20 0.34
FFAR1 O14842 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
LTB4R Q15722 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL386925 0.96 GRM5 (0.38) CXCR2POLBRECQLGRM5GRM2
SCHEMBL386628 0.96 GRM5 (0.38) CXCR2POLBRECQLGRM5GRM2
Oxalic Acid SCHEMBL387856 0.95 FFAR1 (0.38) CXCR2POLBRECQLGRM5GRM2
Oxalic Acid SCHEMBL387032 0.91 POLB (0.36) CXCR2POLBRECQLALDH1A1HTT
Oxalic Acid SCHEMBL386640 0.88 GRM2 (0.40) GRM2GRM3
SCHEMBL386564 0.85 CXCR2 (0.37) CXCR2POLBRECQLGRM5GRM2
SCHEMBL386923 0.85 POLB (0.35) POLBRECQLALDH1A1CYP3A4
Oxalic Acid SCHEMBL387637 0.85 PPARG (0.36) POLBRECQLALDH1A1HTT
SCHEMBL383514 0.83 S1PR4 (0.42) CXCR2POLBRECQLGRM5TSHR
Oxalic Acid SCHEMBL386782 0.83 MAPT (0.40) POLBGRM2GRM3ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101650-B2 Method for treating a immunology-related disease DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-01-24 US disclosed
US-8067396-B2 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2011-11-29 US disclosed
US-20100035842-A1 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2010-02-11 US disclosed
US-20090326038-A1 Method for treating a immunology-related disease SANKYO COMPANY, LIMITED (JP) 2009-12-31 US disclosed
US-7638551-B2 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2009-12-29 US disclosed
EP-1471054-B1 AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE DAIICHI SANKYO CO LTD (JP) 2009-07-01 EP disclosed
US-20070142335-A1 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2007-06-21 US disclosed
US-20070105933-A1 Amino alcohol compounds SANKYO COMPANY, LIMITED (JP) 2007-05-10 US disclosed
US-7199150-B2 Amino alcohol compounds SANKYO COMPANY, LIMITED (JP) 2007-04-03 US disclosed
US-20050043386-A1 Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these SANKYO COMPANY, LIMITED (JP) 2005-02-24 US disclosed
EP-1471054-A1 AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE Sankyo Company, Limited (JP) 2004-10-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043386-A1 Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these PHOSPHO1, CD4, FCGRT CXCR2 2098/4885POLB 2164/4885RECQL 4130/4885
US-20090326038-A1 Method for treating a immunology-related disease C3AR1, HRH3, HRH2 CXCR2 129/4885POLB 4236/4885RECQL 3402/4885
US-20070105933-A1 Amino alcohol compounds ADH1C, C9, SSB CXCR2 290/4885POLB 2273/4885RECQL 4592/4885
US-20070142335-A1 Amino alcohol compounds or phosphonic acid derivatives thereof HRH3, C3AR1, HRH4 CXCR2 489/4885POLB 1738/4885RECQL 4695/4885
US-20100035842-A1 Amino alcohol compounds or phosphonic acid derivatives thereof PHOSPHO1, ADH1C, ADH1A CXCR2 2314/4885POLB 1476/4885RECQL 3257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.